Kyoto University
Department of Early Clinical Development Graduate School of MedicineKyoto University HospitalDepartment of Early Clinical DevelopmentKyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT)
September 2022 to May 2025 We started the following clinical trial “A study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors”
August to December 2022 We started the following clinical trial “An Open-Label, Dose Escalation, Phase 1, First-in Human Study of TAK-102 in Adult Patients with GPC3-Expressing Previously Treated Solid Tumors”
“Study on age-related changes in human immunocompetent cells” (new research on new coronavirus vaccine) has started.
April 2022 to March 2024 We started the following clinical trial “Investigation of Colorectal Cancer-Related Genes Using Peripheral Blood in Healthy Volunteers”
April 2020 to March 2023. Takako Nakajima (Principal Investigator) implementing the project(Health Labour Sciences Research Grant). “Research to establish guideline and social implementation of electronic patient-reported outcome”
« 過去の投稿
新しい投稿 »